Search Results
Found 2 results
510(k) Data Aggregation
(12 days)
RITA SYSTEMS
The RITA® System (RF generator and electrosurgical devices) supplies energy for use in electrosurgery and is indicated for use in percutaneous, laparoscopic, or intraoperative coagulation and ablation of soft tissue, including the partial or complete ablation of non-resectable liver lesions and the palliation of pain associated with metastatic lesions involving bone in patients who have failed or are not candidates for standard pain therapy.
The RITA System consists of the following components:
RF Generator: Provides RF energy to the Device through the Main Cable.
Disposable Electrode ("the Device"): Consists of a number of deployable electrodes. Some or all are equipped with a thermocouple, depending on the model of the Device. Some Devices are used with saline infusion ("Infusion Devices") and require the use of a pump.
Infusion Pump: When using the RF Generator with the Infusion Devices, an off-the-shelf market-cleared infusion pump or a RITA Pump is used to deliver saline through the Infusion Device during ablation. In the off-the-shelf pump, syringes are connected to the Infusion Device and loaded into the Infusion Pump. In the RITA Pump, a Tubing Kit is connected to the Infusion Device and loaded into the RITA Pump. The RF Generator is connected to the Infusion Pump via an RS-232 cable.
Tubing Kit: The tubing kit is designed to load into the pump head from the front of the pump. On the proximal end of the tubing-set there is a PVC Bag Spike fitting that allows the tubing to be attached to an IV bag. The Bag Spike fitting is attached to a single length of tubing that is connected to a splitter fitting that splits the single tubing into 5 separate tubes. The 5 tubes are held together with clips that allow the tubes to be uniformly loaded into the pump head. The distal end on the tubing-set has 5 female luers to attach to the Infusible devices.
Main Cable: Connects the Device to the RF Generator.
Dispersive Electrode: Provides the return path for the RF energy applied by the Device. Depending on the model, the dispersive electrode may be equipped with thermocouples to measure skin temperature at the dispersive pad. Dispersive pads with temperature sensing capabilities are connected to the RF Generator at the dispersive electrode connection and at the Aux port.
Power Cord: A medical grade line cord that provides AC power to the RF Generator.
Foot Pedal: The Foot Pedal is connected to the front of the RF Generator. The Foot Pedal starts and stops the RF energy delivery when the RF Generator is in "READY" mode.
The provided text is a 510(k) summary for the RITA® System, an electrosurgical device. It describes the device, its intended use, and states that performance data exists, but it does not contain specific acceptance criteria or detailed results from a study proving those criteria are met. Instead, it generally states that the device was subjected to various types of testing.
Therefore, I cannot provide the requested table or answer most of the detailed questions because the information is not present in the provided document.
Here's what can be extracted and what cannot:
1. Table of Acceptance Criteria and Reported Device Performance:
- Cannot create this table. The document states: "The RITA System is subjected to design verification, software validation, ablation performance, and sterilization validation testing." However, it does not specify what the acceptance criteria for these tests were or what the reported performance values were.
2. Sample size used for the test set and the data provenance:
- Cannot be determined from the document. The document mentions "ablation performance" testing but provides no details on the study design, sample size, or data provenance (e.g., country of origin, retrospective/prospective nature).
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
- Not applicable / Cannot be determined. This type of information is usually relevant for studies involving human interpretation (e.g., image-based diagnosis). The RITA System is an electrosurgical device, and its performance would likely be assessed through objective measures (e.g., lesion size, temperature, power output) rather than expert ground truth for interpretation. No such expert evaluation is mentioned.
4. Adjudication method for the test set:
- Not applicable / Cannot be determined. As above, adjudication methods are typically used for establishing ground truth from multiple expert opinions, which is not described for this device's performance testing.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, if so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- No, an MRMC study was not done. The RITA System is an electrosurgical device, not an AI-based diagnostic tool that would assist human readers in interpreting data. Therefore, this type of study is irrelevant to this device.
6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:
- Cannot be determined, and likely not applicable in the context of an "algorithm only" device. The RITA System is a physical device (generator, electrodes, pump) operated by a user. Its performance is inherent to the device's function, not a standalone algorithm. While software validation is mentioned, this refers to the software controlling the device, not a diagnostic algorithm.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):
- Cannot be determined. The document only generally refers to "ablation performance" testing without specifying the endpoint measurements or how the "truth" of ablation success was established (e.g., by pathology post-ablation, imaging follow-up, etc.).
8. The sample size for the training set:
- Not applicable / Cannot be determined. Training sets are relevant for machine learning algorithms. The RITA System is a medical device, not an AI model requiring a training set in the conventional sense. "Design verification" and "software validation" might involve internal testing and iteration, but this is distinct from "training data" for an AI.
9. How the ground truth for the training set was established:
- Not applicable / Cannot be determined. (See point 8).
Summary of available information related to performance:
- What was tested: Design verification, software validation, ablation performance, and sterilization validation testing.
- Device Type: Electrosurgical cutting and coagulation device.
- Intended Use: Percutaneous, laparoscopic, or intraoperative coagulation and ablation of soft tissue, including non-resectable liver lesions and palliation of pain from metastatic bone lesions.
Conclusion:
The provided 510(k) summary states that performance testing was conducted, but it lacks the granular detail needed to answer specific questions about acceptance criteria, study sizes, ground truth establishment, or specific performance metrics. It's a high-level overview for regulatory clearance based on substantial equivalence to a predicate device, not a detailed scientific publication of study results.
Ask a specific question about this device
(166 days)
RITA SYSTEM
The RITA® System (RF generator and electrosurgical devices) supplies energy for use in electrosurgery and is indicated for use in percutaneous, laparoscopic, or intraoperative coagulation and ablation of soft tissue, including:
- the partial or complete ablation of non-resectable liver lesions and
- the palliation of pain associated with metastatic lesions involving bone in patients who have failed or are not candidates for standard pain therapy.
The RITA System (RF Generator and electrosurgical devices) is designed to create coagulative necrotic lesions in soft tissue, and allow localized delivery of fluid to the lesion. The RF Generator is specifically designed for use with RITA Electrosurgical Devices (Accessories). The RF Generator provides multiple temperature sensors, impedance, and power monitoring to assist the user in delivering the desired energy to the target tissue. The electrosurgical devices consist of monopolar electrosurgical devices that include disposable electrosurgical probes with deployable needle arrays that deliver RF power with temperature and impedance monitoring to ablate predictable volumes of tissue.
The provided text describes the RITA® System, an electrosurgical device, and its intended use and performance data. However, it does not contain the detailed information necessary to fully answer all aspects of your request regarding acceptance criteria and a specific study proving device performance against those criteria.
Here's what can be extracted and what information is missing:
1. Table of Acceptance Criteria and Reported Device Performance
The document does not explicitly state formal acceptance criteria (e.g., target specificity, sensitivity, or similar metrics for a diagnostic device). Instead, it describes a clinical study and its observed outcomes as a measure of effectiveness.
Acceptance Criteria | Reported Device Performance |
---|---|
(Not explicitly defined in terms of specific performance metrics for this device, which is a therapeutic device for ablation and pain palliation) | Effectiveness for Pain Palliation (Worst Pain): 75% of patients experienced at least a two-point reduction in "worst pain" from baseline to week four. |
Effectiveness for Pain Palliation (Average Pain): 80% of patients experienced at least a two-point reduction in "average pain" from baseline to week four. | |
Safety/Morbidity: Low attendant morbidity (no reports of death related to use of the devices). | |
Adverse Events: Three adverse events potentially related to RF ablation. | |
(Bench study findings on ablation characteristics/parameters) | Bench studies determined the effect of the bone environment on ablation characteristics and parameters. (Specific quantitative results not provided). |
2. Sample Size Used for the Test Set and Data Provenance
- Sample Size: The document does not explicitly state the total number of patients in the clinical study. It refers to percentages of "patients" (75% and 80%) but not the base number.
- Data Provenance: The study was conducted on "patients with lesions that had metastasized to one or more locations in the skeleton." It is a prospective clinical study assessing safety and effectiveness. The country of origin for the data is not specified.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Their Qualifications
This information is not provided in the document. For a therapeutic device like this, "ground truth" would typically relate to clinical outcomes rather than expert-derived labels on images.
4. Adjudication Method for the Test Set
This information is not provided in the document. Given the nature of pain palliation as an endpoint, "adjudication" in the sense of expert consensus on image interpretation is less relevant. The effectiveness was measured using a "validated instrument for evaluating cancer pain," suggesting a standardized assessment.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, and the Effect Size
This information is not provided. The study described is a clinical study evaluating the device's effectiveness in alleviating pain, not a comparative effectiveness study involving human readers with/without AI assistance. The device itself is an RF ablation system, not an AI diagnostic tool that assists human readers.
6. If a Standalone (Algorithm Only Without Human-in-the-Loop Performance) Study Was Done
This question is not applicable to the RITA® System as described. It is a physical medical device (RF generator and electrosurgical devices) that requires direct human operation, not a standalone algorithm. The "performance" refers to the device's clinical efficacy and safety when used by a clinician.
7. The Type of Ground Truth Used
The "ground truth" for the effectiveness of the RITA® System's pain palliation indication was based on:
- Outcomes Data: Specifically, patient-reported pain levels assessed using an "instrument validated for evaluating cancer pain."
- Safety Data: Observed adverse events and mortality related to the device's use.
8. The Sample Size for the Training Set
This information is not applicable/not provided. The RITA® System is a physical electrosurgical device, not a machine learning algorithm that requires a "training set" in the computational sense. The "bench studies" mentioned would involve laboratory testing, not a data training set.
9. How the Ground Truth for the Training Set Was Established
This question is not applicable for the same reasons as #8. There is no "training set ground truth" in the context of this device.
In summary, the provided text describes a clinical study demonstrating the RITA® System's effectiveness in pain palliation and its safety profile. However, it does not detail specific, quantitative acceptance criteria in a tabular format, nor does it address aspects related to AI/algorithm performance (like training sets, expert adjudication, or MRMC studies) as the device is a therapeutic electrosurgical system.
Ask a specific question about this device
Page 1 of 1